Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil versus ciclosporin A in children with frequently relapsing or steroid-dependent idiopathic nephrotic syndrome
NL-OMON22419Active, not recruiting
- Sponsor
- N/A
- Start
- Dec 2002
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial in Idiopathic nephrotic syndrome (INS) and nephrosis comparing Mycophenolate mofetil with Ciclosporin A (2 arms). Primary endpoint: Glomerular filtration rate. Started Dec 2002; status: active, not recruiting.
02
Drugs
mycophenolate mofetilcyclosporine
03
Conditions
Idiopathic nephrotic syndrome (INS)nephrosis
Beyond the preview
Go deeper on NL-OMON22419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22419.